checkAd

     508  0 Kommentare The Global Radiopharmaceutical Market Forecast 2017-2027 - Seite 3

    Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

    Information found nowhere else: 

    With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

    Visiongain's study is for everybody needing commercial analyses for the Biosimulation market and leading companies. You will find data, trends and predictions.

    Get our report today The Global Radiopharmaceutical Market Forecast 2017-2027: Revenue Prospects by Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Others) Radioisotope (Tc-99, F-18, I-131, Lu-177, Y-90, Ga-68, Ga-67, Rb-82, I-123, I-125, I-111, Others), Source (Cyclotrons, Nuclear Reactors), End User (Hospitals, Diagnostic Imaging Centres, Ambulatory Surgical Centres, Cancer Research Institutes) and Geography. Avoid missing out - get our report now.

    To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

    Or click on https://www.visiongain.com/Report/1923/The-Global-Radiopharmaceutical-Market-Forecast-2017-2027

    List of Companies: 

    ABX GmbH

    Actinium Pharmaceuticals, Inc.

    Advanced accelerator applications S.A

    Advion, Inc.

    Alliance Medical

    ANMI

    Avid Radiopharmaceuticals

    Bayer

    Biodex

    Biomedica Life Sciences S.A

    Bracco Imaging S.P.A

    BV Cyclotron VU

    Cardinal Health, Inc.

    Clarity Pharmaceuticals

    Comecer Group

    Coquí RadioPharmaceuticals, Corp.

    Coquí RadioPharmaceuticals, Corp.

    Cyclomedical

    Cyclopharm

    Danish International

    DuChemBio Co., Ltd

    Eckert & Ziegler

    Eczacıbaşı-Monrol Nuclear Products

    Eli Lilly and Company

    ELYSIA s.a.

    Euromechanics saveRay GmbH

    FUJIFILM Holdings Corporation

    GIPHARMA

    IDB Holland BV

    Immunomedics, Inc.

    Ion Beam Applications

    IQ Medical Services

    Isologic Innovative Radiopharmaceuticals

    Isorad Ltd

    IsoTherapeutics Group, LLC

    Jubilant Pharma. LLC

    Lantheus Medical Imaging, Inc.

    M.G.P.

    M.G.P. spol. s r. o.

    Medi-Radiopharma

    Modus Medical Devices Inc.

    MR Solutions

    Navidea Biopharmaceuticals, Inc.

    Nordion, Inc

    OctreoPharm Sciences GmbH

    Optimized Radiochemical Applications

    PARS ISOTOPE Co.

    PET Pharm Biotech Co., Ltd

    Piramal Group

    Rapidscan Pharma Solutions

    ROTOP Pharmaka GmbH

    RPH Group

    SANLAR Group

    SCETI K.K

    Shertech Pharmacy

    Siemens AG

    Siemens Healthineers

    Sirtex Medical Europe GmbH

    SK CAPITAL

    St Mary's Pharmaceutical

    Synektik Group

    Tema Sinergie

    The Voxel S.A.

    Toshiba Medical Systems Corporation

    Tracer Pharma ApS

    TRASIS S.A.

    Triad Isotopes, Inc.

    Zevacor Molecular

    Zevacor Pharma, Inc.

    To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

    Seite 3 von 3



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    The Global Radiopharmaceutical Market Forecast 2017-2027 - Seite 3 LONDON, July 21, 2017 /PRNewswire/ - Revenue Prospects by Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, Nephrology, Others) Radioisotope (Tc-99, F-18, I-131, Lu-177, Y-90, Ga-68, Ga-67, Rb-82, I-123, I-125, …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer